Our Press Releases

Press Release

Oncology CRO Oncotherapeutics Presents at ASH 2011 Annual Meeting

Los Angeles, Nov 23, 2011 — Oncotherapeutics, an oncology specific Contract Research Organization (CRO) specializing in the oversight and management of clinical trials for cancer, will present final results from a multicenter clinical trial at the American Society of Hematology Annual Meeting in San Diego, California on December 10-13 , 2011.

Press Release

Kyphon® Balloon Kyphoplasty Found Beneficial for Treating Spinal Fractures in Cancer Patients

The results of this landmark study should be welcomed news to cancer patients across the world suffering from the debilitating effects of painful vertebral compression fractures,” said Dr. James Berenson, the study’s first author and Medical and Scientific Director of the Institute for Myeloma and Bone Cancer Research in Los Angeles, CA. “It is documented that nearly one-fourth (24 percent) of patients with multiple myeloma, 14 percent with breast cancer, 8 percent with lung cancer and 6 percent with prostate cancer suffer painful vertebral compression fractures. With the results of this new randomized study, there is now clinical evidence of a treatment option for spinal fractures in cancer patients that can provide excellent relief of pain and improved quality of life.”

Press Release

Los Angeles Non Profit Cancer Research Institute Hosts Beverly Hills Art Reception Featuring Rare Collections of Picasso, Miro and Dali and Never Before Seen Photographs of Marilyn Monroe.

Institute for Myeloma and Bone Cancer Research’s Fall Art Benefit offers an afternoon of art appreciation and auction, wine, and hors d’oeuvres at the Andrew Weiss Gallery in Beverly Hills, CA.

Press Release

Institute for Myeloma and Bone Cancer Research in Los Angeles Proudly Announces Roger Townsend to join its Board of Directors as Treasurer.

Roger Townsend makes the transition to IMBCR’s board of directors after serving two years on its Audit Committee.

Press Release

Reunion Beer Kicks Off 2010 Fundraising Campaign With Release of Belgian-Style Scotch Ale

REUNION – A Beer for Hope, now in its fourth year, today announced the release of its 2010 special brew, a Belgian-Style Scotch Ale.View pdf

Press Release

Benefit Gala of “Cooking with Stella” to open the 8th annual Indian Film Festival Los Angeles

IFFLA opening supports the work of the Institute for Myeloma & Bone Cancer Research

Variety

IFFLA opens with ‘Stella’

Benefits IMBCR Indian Film Festival takes place in L.A. on April 20

Manhattan Beach Sun January 2010

Coordinating Council Hears Positive News from Dr Berenson

I-Newswire December 2009

Institute for Myeloma and Bone Cancer Research featured at American Society of Hematology 2009

CEO and founder, James R. Berenson, MD and IMBCR researchers will present the 9 papers, oral presentations and special sessions December 5-8, 2009 at the 51st ASH Annual Meeting and Exposition.

Video Feature July 2009

Dr. Jim Berenson is featured on KTLA-Channel 5’s prime time news segment from Emmy award winning news anchor, Emmett Miller as he follows the story of a courageous young police officer who is battling multiple myeloma.

Press Release January 2009

Institute for Myeloma and Bone Cancer Research in Los Angeles Proudly Announces that Ethan Horwitz, Esq of King & Spalding Law Firm has joined its Board of Directors.

Press Release February 2009

Researchers Identify Novel Mechanism That Make Cancer Tumors Grow

Scientists at the Institute for Myeloma and Bone Cancer Research (IMBCR) have uncovered a new pathway that could explain how blood vessels form within tumors.

Press Release January 2009

One Million Dollars awarded to Institute for Myeloma and Bone Cancer Research

FJC, a New York-based donor advised fund, is the latest organization to grant major funding to the “Cure Myeloma Project”, an ongoing research initiative at the Institute for Myeloma and Bone Cancer Research, (IMBCR), in Los Angeles, CA


Press Release December 2008

Myeloma Research Fund Grants Institute for Myeloma and Bone Cancer Research an additional $200,000 for “Cure Myeloma Project”.

Part of the Institute for Myeloma and Bone Cancer Research (IMBCR) “Cure Myeloma Project”, this funding will further explore new targeted therapeutic approaches against Multiple Myeloma with hopes of creating groundbreaking new treatments against malignant myeloma cells and devastating bone loss.


Press Release November 2008

Institute for Myeloma and Bone Cancer Research Announces Upcoming Oral and Poster Presentations at the 2008 American Society of Hematology (ASH) Annual Meeting

Two oral presentations and three poster presentations will be offered by researchers from the Institute for Myeloma and Bone Cancer Research celebrating the 50th Annual Meeting of the American Society of Hematology (ASH). More Information…


Press Release June 2008

Multiple Myeloma Expert Featured on XM Satellite Radio

Myeloma Specialist Dr. James R. Berenson Featured on ReachMD’s “Clinician’s Roundtable” Read the Article…


XM Satellite Radio June 2008

Dr. Berenson featured on ReachMD XM Satellite Radio Channel 157 “Multiple Myeloma: Current Treatment Modalities” Free registration required.


I-Newswire.com March 2008

Multiple Myeloma expert, James R. Berenson, MD, featured on free telephone workshop, “Caring for Your Bones When You Have Multiple Myeloma” April 2, 2008.


I-Newswire.com February 2008

The Institute for Myeloma and Bone Cancer Research announces Roger Fischer and Alvin Dischler have been appointed to its Board of Directors.


I-Newswire.com February 2008

“Ask the Expert” Launched

(I-Newswire) – Los Angeles, CA – MMSupport.net and the Institute for Myeloma and Bone Cancer Research are proud to announce the creation of “Ask the Expert”, a free online web-forum featuring Multiple Myeloma expert, Dr. James R. Berenson.


I-Newswire.com January 2008

The Institute for Myeloma and Bone Cancer Research announces the addition of Zhi-Wei Li, Ph.D. as Principal Scientist for “The Cure Myeloma Project”

Zhi-Wei Li, Ph.D. formerly of The Moffitt Cancer Research Center affiliated with the University of South Florida will lead scientific efforts for the Institute of Myeloma and Bone Cancer Research’s most recent research initiative, “The Cure Myeloma Project.”


Patientpower.com November 2007

Contemporary Issues in Relapsed-Refractory Myeloma

We’ve been receiving hundreds of questions from myeloma patients. While we can’t answer them all, they do tend to cover common ground. We’ll address key topics in our next live webcast, the fourth in a series of 7 programs. Join us for our discussion with Dr. James Berenson, Founder, President and CEO of the Institute for Myeloma and Bone Cancer Research.

Replay Available here .


Coping with Cancer May/June 2007

New Developments in Multiple Myeloma Management

Positive results from numerous clinical trials have led to a rapid increase in the therapeutic options now available to effective care for people with multiple myeloma

Read the Article…

Coping_Mag_5-07


Seattle Weekly March 7, 2007

More Helpful, Less Wicked

Old-school Pete’s Wicked Ale gang gets back together for a charity brew.

Former Pete’s sales manager Alan Shapiro contacted Slosberg about getting the Wicked gang back together for a charity project in her honor. All of the profits of the brew they have named “Reunion: A Beer for Hope” will benefit the Institute for Myeloma and Bone Cancer Research (IMBCR).

Read the Article…


Myeloma Focus – Newsletter of the MMRF Spring 2007

Funding Research

MMRF Announces 2006 Compound Validation Award Winners

The MMRF is pleased to announce five Compound Validation Awards, each valued at $100,000 to researchers at five outstanding institutions. Read the article…

mmrf_newsletter


MorningNewsBeat.com March 2007

Retail News in Context, Analysis with Attitude by Kevin Coupe

Considering that cancer has been so much in the news the last two weeks, it was ironic that I got a chance to taste the new Reunion Imperial Brown Ale, described as a “beer for hope.” Read the article…

morningnewsbeat


Publications

IONlink August 2006

A Phase I/II Study of Trisenox®, VELCADE® and Ascorbic Acid in Relapsed/Refractory Multiple Myeloma. Read the article…

ionlink1


Oncology Times August 2006

Zoledronic Acid Extends Survival In Lung Cancer & Multiple Myeloma Patients With High Levels of Bone Metabolism. Read the article…

oncology_times1


Winter 2005 Newsletter

Click here to download and view the Winter 2005 Newsletter.

Winter-2005.newsletter


American Cancer Society November 2005

Safety of Prolonged Therapy with Bortezomib in Relapsed or Refractory Multiple Myeloma Read the article…